pharmaphorum looks at its evolution over the centuries. The roots of the pharmaceutical industry lie back with the apothecaries and pharmacies that offered traditional remedies as far back as the ...

The pharmaceutical industry experienced a period of rapid growth during the COVID-19 pandemic. Even companies that were not working directly on treatments and vaccines were still able to lend ...

IPC Indice de Precios Y Cotizaciones 52,817.75 142.96 0.27% ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

“Almost all the members of this panel, including yourself, are accepting millions of dollars from the pharmaceutical industry and protecting their interests.” Kennedy’s backers have ...

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Alex Guillen, global pharma and life sciences director at Tive, outlines the technological obstacles that lie ...

A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.

Feb. 4, 2025 — A new study shows how an anticancer drug triggers an 'outside in' signal that gets it sucked into a cancer cell. The work reveals a new signaling mechanism that could be exploited ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers.

What does Nifty Pharma represent? Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends ...

5 February 2025 The US Food and Drug Administration (FDA) has approved Susvimo (ranibizumab injection) 100mg/mL for the treatment of diabetic macular edema (DME), said Swiss pharma giant Roche.